(Q37641063)

21 August 2017

1 reference

title

New perspectives on the biology of acute GVHD. (English)

1 reference

21 August 2017

S Paczesny

1

1 reference

21 August 2017

D Hanauer

series ordinal

2

1 reference

21 August 2017

Y Sun

series ordinal

3

1 reference

21 August 2017

P Reddy

series ordinal

4

1 reference

21 August 2017

language of work or name

English

0 references

publication date

30 November 2009

1 reference

Bone Marrow Transplantation

21 August 2017

published in

1 reference

21 August 2017

volume

45

1 reference

21 August 2017

issue

1

1 reference

21 August 2017

page(s)

1-11

1 reference

Lethal graft-versus-host disease after bone marrow transplantation across minor histocompatibility barriers in mice. Prevention by removing mature T cells from marrow

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

Genetics of risk factors for graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

Identification of a graft versus host disease-associated human minor histocompatibility antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

A human minor histocompatibility antigen resulting from differential expression due to a gene deletion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

Molecules and mechanisms of the graft-versus-leukaemia effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

Recognition of microorganisms and activation of the immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

Tumor necrosis factor- alpha production to lipopolysaccharide stimulation by donor cells predicts the severity of experimental acute graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

Blockade of interleukin-6 signaling augments regulatory T-cell reconstitution and attenuates the severity of graft-versus-host disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

TLR agonists regulate alloresponses and uncover a critical role for donor APCs in allogeneic bone marrow rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

The host environment regulates the function of CD8+ graft-versus-host-reactive effector cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

NODs: intracellular proteins involved in inflammation and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

Both donor and recipient NOD2/CARD15 mutations associate with transplant-related mortality and GvHD following allogeneic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

CD24 and Siglec-10 selectively repress tissue damage-induced immune responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

Dendritic cells and the control of immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

Depletion of host Langerhans cells before transplantation of donor alloreactive T cells prevents skin graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

Graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

Enhancing immunity through autophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

CCR9 expression defines tolerogenic plasmacytoid dendritic cells able to suppress acute graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

Differential rates of replacement of human dermal dendritic cells and macrophages during hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

T cell anergy and costimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

21 January 2018

The B7-CD28 superfamily

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

Costimulatory pathways in transplantation: challenges and new developments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

Absence of inducible costimulator on alloreactive T cells reduces graft versus host disease and induces Th2 deviation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

Blockade of programmed death-1 engagement accelerates graft-versus-host disease lethality by an IFN-gamma-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

Induction of natural killer T cell-dependent alloreactivity by administration of granulocyte colony-stimulating factor after bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

Histone deacetylase inhibitor suberoylanilide hydroxamic acid reduces acute graft-versus-host disease and preserves graft-versus-leukemia effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

Cutting edge: Negative regulation of dendritic cells through acetylation of the nonhistone protein STAT-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

Antibody to the dendritic cell surface activation antigen CD83 prevents acute graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

Critical role of host gammadelta T cells in experimental acute graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

In vivo trafficking and survival of cytokine-induced killer cells resulting in minimal GVHD with retention of antitumor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

Host natural killer T cells induce an interleukin-4-dependent expansion of donor CD4+CD25+Foxp3+ T regulatory cells that protects against graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

Host NKT cells can prevent graft-versus-host disease and permit graft antitumor activity after bone marrow transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

NKT cell-dependent leukemia eradication following stem cell mobilization with potent G-CSF analogs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

Invariant natural killer T cell-natural killer cell interactions dictate transplantation outcome after alpha-galactosylceramide administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

Host B cells produce IL-10 following TBI and attenuate acute GVHD after allogeneic bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

Prevention of acute graft-versus-host disease by blocking T-cell entry to secondary lymphoid organs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

Effects of donor T-cell trafficking and priming site on graft-versus-host disease induction by naive and memory phenotype CD4 T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

A uniform genomic minor histocompatibility antigen typing methodology and database designed to facilitate clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

Overlap between in vitro donor antihost and in vivo posttransplantation TCR Vbeta use: a new paradigm for designer allogeneic blood and marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

Memory CD4+ T cells do not induce graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

Transfer of allogeneic CD62L- memory T cells without graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

L-Selectin(hi) but not the L-selectin(lo) CD4+25+ T-regulatory cells are potent inhibitors of GVHD and BM graft rejection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

Effector memory CD4+ T cells mediate graft-versus-leukemia without inducing graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

Lymphodepletion followed by donor lymphocyte infusion (DLI) causes significantly more acute graft-versus-host disease than DLI alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

Alloreactive memory T cells are responsible for the persistence of graft-versus-host disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

Host-reactive CD8+ memory stem cells in graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

Naive and memory T cells induce different types of graft-versus-host disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

The role of CD4+CD25hi regulatory T cells in the physiopathogeny of graft-versus-host disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

Inhibition of graft-versus-host disease by double-negative regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

Bone marrow NK1.1(-) and NK1.1(+) T cells reciprocally regulate acute graft versus host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

Foxp3 in control of the regulatory T cell lineage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

Delayed apoptotic cell clearance and lupus-like autoimmunity in mice lacking the c-mer membrane tyrosine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

Post-hematopoietic cell transplantation control of graft-versus-host disease by donor CD425 T cells to allow an effective graft-versus-leukemia response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

The biology and therapeutic potential of natural regulatory T-cells in the bone marrow transplant setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

The impact of regulatory T cells on T-cell immunity following hematopoietic cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

Combined CD4+ donor lymphocyte infusion and low-dose recombinant IL-2 expand FOXP3+ regulatory T cells following allogeneic hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

Graft-versus-host disease: the influence of type 1 and type 2 T cell cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

Pathophysiology of acute graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

T cell-directed therapies: lessons learned and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

Inhibition of CD4+CD25+ regulatory T-cell function by calcineurin-dependent interleukin-2 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

Thymic development and peripheral homeostasis of regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

Donor-derived interferon gamma is required for inhibition of acute graft-versus-host disease by interleukin 12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

Interleukin-18 regulates acute graft-versus-host disease by enhancing Fas-mediated donor T cell apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

IFN differentially controls the development of idiopathic pneumonia syndrome and GVHD of the gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

Interleukin-11 promotes T cell polarization and prevents acute graft-versus-host disease after allogeneic bone marrow transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

Pretreatment of donors with interleukin-18 attenuates acute graft-versus-host disease via STAT6 and preserves graft-versus-leukemia effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

Ex vivo rapamycin generates donor Th2 cells that potently inhibit graft-versus-host disease and graft-versus-tumor effects via an IL-4-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

Th2 and Tc2 cells in the regulation of GVHD, GVL, and graft rejection: considerations for the allogeneic transplantation therapy of leukemia and lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

Combined Th2 cytokine deficiency in donor T cells aggravates experimental acute graft-vs-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

Th1 and Th2 mediate acute graft-versus-host disease, each with distinct end-organ targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

Absence of donor Th17 leads to augmented Th1 differentiation and exacerbated acute graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

IL-17 contributes to CD4-mediated graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

In vitro-differentiated TH17 cells mediate lethal acute graft-versus-host disease with severe cutaneous and pulmonary pathologic manifestations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

Chemokines, sphingosine-1-phosphate, and cell migration in secondary lymphoid organs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

The immunopathology of thymic GVHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

Determining thymic output quantitatively: using models to interpret experimental T-cell receptor excision circle (TREC) data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

Acute graft-versus-host disease transiently impairs thymic output in young patients after allogeneic hematopoietic stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

A revision of Billingham's tenets: the central role of lymphocyte migration in acute graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

Leukocyte migration and graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

Active participation of CCR5(+)CD8(+) T lymphocytes in the pathogenesis of liver injury in graft-versus-host disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

Differential roles for CCR5 expression on donor T cells during graft-versus-host disease based on pretransplant conditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

Critical role for CCR5 in the function of donor CD4+CD25+ regulatory T cells during acute graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

Absence of beta7 integrin results in less graft-versus-host disease because of decreased homing of alloreactive T cells to intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

Cytolytic pathways in haematopoietic stem-cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

TNF-TNFR2 interactions are critical for the development of intestinal graft-versus-host disease in MHC class II-disparate (C57BL/6J-->C57BL/6J x bm12)F1 mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

IL-12-independent LIGHT signaling enhances MHC class II disparate CD4+ T cell alloproliferation, IFN-gamma responses, and intestinal graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

Selective targeting of the LIGHT-HVEM costimulatory system for the treatment of graft-versus-host disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

Effector cells derived from host CD8 memory T cells mediate rapid resistance against minor histocompatibility antigen-mismatched allogeneic marrow grafts without participation of perforin, Fas ligand, and the simultaneous inhibition of 3 tumor necro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs.-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

Immunobiology of allogeneic hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

Cytoscape: a software environment for integrated models of biomolecular interaction networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

Influence of bone marrow graft B lymphocyte subsets on outcome after HLA-identical sibling transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

Foxp3-dependent programme of regulatory T-cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

Prevention of graft versus host disease by inactivation of host antigen-presenting cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

7 January 2021

A crucial role for antigen-presenting cells and alloantigen expression in graft-versus-leukemia responses

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

7 January 2021

Donor APCs are required for maximal GVHD but not for GVL

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

7 January 2021

Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

7 January 2021

Target antigens determine graft-versus-host disease phenotype

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

7 January 2021

Immunodominance of H60 is caused by an abnormally high precursor T cell pool directed against its unique minor histocompatibility antigen peptide

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

7 January 2021

Adoptive transfer of minor histocompatibility antigen-specific T lymphocytes eradicates leukemia cells without causing graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

7 January 2021

Prognostic significance of NOD2/CARD15 variants in HLA-identical sibling hematopoietic stem cell transplantation: effect on long-term outcome is confirmed in 2 independent cohorts and may be modulated by the type of gastrointestinal decontamination

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

7 January 2021

Plasmacytoid dendritic cells prime alloreactive T cells to mediate graft-versus-host disease as antigen-presenting cells

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

7 January 2021

Graft-versus-host disease prevents the maturation of plasmacytoid dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

7 January 2021

Ligation of 4-1BB (CDw137) regulates graft-versus-host disease, graft-versus-leukemia, and graft rejection in allogeneic bone marrow transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

7 January 2021

CD30/CD30 ligand (CD153) interaction regulates CD4+ T cell-mediated graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

7 January 2021

Ligation of OX40 (CD134) regulates graft-versus-host disease (GVHD) and graft rejection in allogeneic bone marrow transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

7 January 2021

Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death: a study from the Acute Leukemia Working Party of the European Group for B

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

7 January 2021

Expansion of cytolytic CD8(+) natural killer T cells with limited capacity for graft-versus-host disease induction due to interferon gamma production

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

7 January 2021

Induction of tumor immunity following allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

7 January 2021

Only the CD62L+ subpopulation of CD4+CD25+ regulatory T cells protects from lethal acute GVHD

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

7 January 2021

https://api.crossref.org/works/10.1038%2FBMT.2009.328

1 reference

7 January 2021

CD4(+)CD25(+) immunoregulatory T Cells: new therapeutics for graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

7 January 2021

The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

7 January 2021

Isolation of CD4+CD25+ regulatory T cells for clinical trials

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

7 January 2021

Cytokine expanded myeloid precursors function as regulatory antigen-presenting cells and promote tolerance through IL-10-producing regulatory T cells

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

7 January 2021

Lymphopenia and interleukin-2 therapy alter homeostasis of CD4+CD25+ regulatory T cells

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

7 January 2021

Donor-derived interferon gamma separates graft-versus-leukemia effects and graft-versus-host disease induced by donor CD8 T cells

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

7 January 2021

Ex vivo rapamycin generates Th1/Tc1 or Th2/Tc2 Effector T cells with enhanced in vivo function and differential sensitivity to post-transplant rapamycin therapy

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

7 January 2021

Factors affecting thymic function after allogeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

7 January 2021

Role of CXCR3-induced donor T-cell migration in acute GVHD

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

7 January 2021

Expression of chemokines in GVHD target organs is influenced by conditioning and genetic factors and amplified by GVHR

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

7 January 2021

TRAIL-transduced dendritic cells protect mice from acute graft-versus-host disease and leukemia relapse

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

7 January 2021

T cells require TRAIL for optimal graft-versus-tumor activity

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

7 January 2021

Interleukin-1 is a critical effector molecule during cytokine dysregulation in graft versus host disease to minor histocompatibility antigens

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.328

7 January 2021

Cytokine dysregulation and acute graft-versus-host disease

1 reference

12 December 2020

The biology of graft-versus-host reactions

1 reference

12 December 2020

In vivo blockade of CD28/CTLA4: B7/BB1 interaction with CTLA4-Ig reduces lethal murine graft-versus-host disease across the major histocompatibility complex barrier in mice

1 reference

12 December 2020

Polarized type 2 alloreactive CD4+ and CD8+ donor T cells fail to induce experimental acute graft-versus-host disease

1 reference

12 December 2020

Donor CD4-enriched cells of Th2 cytokine phenotype regulate graft-versus-host disease without impairing allogeneic engraftment in sublethally irradiated mice

1 reference

12 December 2020

Effect of total body irradiation, busulfan-cyclophosphamide, or cyclophosphamide conditioning on inflammatory cytokine release and development of acute and chronic graft-versus-host disease in H-2-incompatible transplanted SCID mice

1 reference

12 December 2020

Pretreatment of donor mice with granulocyte colony-stimulating factor polarizes donor T lymphocytes toward type-2 cytokine production and reduces severity of experimental graft-versus-host disease

1 reference

12 December 2020

Interferon-gamma suppresses T-cell proliferation to mitogen via the nitric oxide pathway during experimental acute graft-versus-host disease

1 reference

12 December 2020

Blockade of CD40 ligand-CD40 interaction impairs CD4+ T cell-mediated alloreactivity by inhibiting mature donor T cell expansion and function after bone marrow transplantation

1 reference

12 December 2020

Total body irradiation and acute graft-versus-host disease: the role of gastrointestinal damage and inflammatory cytokines

1 reference

12 December 2020

Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation

1 reference

12 December 2020

The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantation

1 reference

12 December 2020

Activation of macrophage cytostatic effector mechanisms during acute graft-versus-host disease: release of intracellular iron and nitric oxide-mediated cytostasis.

1 reference

12 December 2020

Histone deacetylase inhibition modulates indoleamine 2,3-dioxygenase–dependent DC functions and regulates experimental graft-versus-host disease in mice

1 reference

12 December 2020

Identifiers

DOI

10.1038/BMT.2009.328

1 reference

21 August 2017

0 references

1 reference